Diabetes mellitus and hepatitis C

Authors: Petr Husa;  Petr Husa Jr
Authors‘ workplace: Klinika infekčních chorob LF MU a FN Brno, pracoviště Bohunice
Published in: Forum Diab 2016; 5(3): 134-136
Category: Foreign Post


Extrahepatic manifestations of hepatitis C virus infection (HCV) are very common. A link with the HCV infection is considered to be established with membranoproliferative glomerulonephritis, leukocytoclastic vasculitis, lympho­proliferative disorders (in particular B-cell lymphoma), Sjögren and sicca syndrome, lichen planus, porfyria cutanea tarda and diabetes mellitus. Antiviral therapy may prevent progression to diabetes in patients with prediabetes who have hepatitis C and may reduce renal and cardiovascular complications in patients with established diabetes who have hepatitis C.

Key words:
extrahepatic manifestations – chronic hepatitis C – direct acting antivirals


1. European Association for the Study of Liver. EASL recommendations on treatment of hepatitis C 2016. Summary. Dostupné z WWW: <http://www.easl.eu/medias/cpg/HCV2016/Summary.pdf>.

2. Tillmann HL, McHutchison JG. Hepatitis C. In: Boyer TD, Manns MP, Sanyal A. Zakim and Boyer´s Hepatology: A Textbook of Liver Disease. 6th ed. Elsevier Saunders: Philadelphia 2012: 574–576. ISBN 978–1437708813.

3. American Association for the study of Liver Diseases (AASLD). HCV Guidance: Recommendation for testing, managing, and treating hepatitis C. Dostupné z WWW: <http://www.hcvguidelines.org/>.

4. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes. A systematic review and meta-analysis. J Hepatol 2008; 49(5): 831–844. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2008.08.006>.

5. Mehta SH, Brancati FL, Sulkowski MS et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133(8): 592–599.

6. Yoneda M, Saito S, Ikeda T et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J Viral Hepat 2007; 14(9): 600–607.

7. Petta S, Camma C, Di Marco V et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 2008; 103(5): 1136–1144. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1572–0241.2008.01813.x>.

8. Hung CH, Wang JH, Hu TH et al. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 2010; 16(18): 2265–2271.

9. Arase Y, Suzuki F, Suzuki Y et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 2009; 49(3): 739–744. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.22703>.

10. Hsu YC, Lin JT, Ho HJ et al. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology 2014; 59(4): 1293–1302. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.26892>.

11. Hsu YC, Ho HJ, Huang YT et al. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut 2015; 64(3): 495–503. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2014–308163>.

12. University of Liverpool. Drug interactions charts. Dostupné z WWW: <http://www.hep-druginteractions.org/>.

Diabetology Endocrinology Internal medicine
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account